Open Beta
MetriLume

US marketsKRRO

SEC-sourced researchBeta

KRRO

Korro Bio, Inc.

Company comparison ↗

Data passport

CIK
0001703647
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 2,271,000.0000 USD; December 2025: 6,392,000.0000 USD6.4M USD0 USD0December 2024December 2025
KRRO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20242,271,000.0000Mar 12, 2026
December 20256,392,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20256,392,000.0000-117,260,000.0000-78,561,000.0000113,506,000.000062,067,000.0000Mar 12, 2026
December 20242,271,000.0000-83,581,000.0000-60,074,000.0000226,240,000.000065,825,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$6.39MDecember 2025Mar 12, 202610-K
Previous period revenueRevenues$2.27MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$117.26MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$78.56MDecember 2025Mar 12, 202610-K
Total assetsAssets$113.51MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$62.07MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗